6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2-amine

Catalog No. :
ACYLHT049
CAS No. :
2161304-72-7
Molecular Formula :
C15H19BN2O2
Molecular Weight :
270.14

IUPAC Name:6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2-amine

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$120.00Login to see priceIn stockInquiry
250mg95%$240.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2-amine
IUPAC Name6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2-amine
Molecular FormulaC15H19BN2O2
Molecular Weight270.14
SMILESCC1(C)OB(OC1(C)C)C1=CC=C2N=C(N)C=CC2=C1
InChI KeyFJZJAFAEGWWVHI-UHFFFAOYSA-N
Synonym6-(Tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2-amine;2-Quinolinamine, 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2-amine
CAS No.2161304-72-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYLHT049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACFKTH869 route compound structure diagram
    ACFKTH869791626-58-9 In Stock
  4. Then
  5. ACYLHT049 route product structure diagram
    ACYLHT0492161304-72-7 In Stock
Inquiry

2. ACYLHT049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYLHT049 route product structure diagram
    ACYLHT0492161304-72-7 In Stock
Inquiry

Comments (0)